These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27869291)

  • 1. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2017 Jan; 101(1):8-12. PubMed ID: 27869291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
    Potter BK
    Clin Orthop Relat Res; 2016 Apr; 474(4):892-4. PubMed ID: 26872915
    [No Abstract]   [Full Text] [Related]  

  • 3. Defining "innovativeness" in drug development: a systematic review.
    Kesselheim AS; Wang B; Avorn J
    Clin Pharmacol Ther; 2013 Sep; 94(3):336-48. PubMed ID: 23722626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the innovation supply chain to maximize personalized medicine.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2014 Feb; 95(2):113-8. PubMed ID: 24448453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIPTE: a multi-university partnership supporting academic drug development.
    Gurvich VJ; Byrn SR
    Drug Discov Today; 2013 Oct; 18(19-20):916-21. PubMed ID: 23732177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health, Wealth, and the 21st Century Cures Act.
    Lo AW; Philipson TJ; von Eschenbach AC
    JAMA Oncol; 2016 Jan; 2(1):17-8. PubMed ID: 26513279
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biomarkers: "Found in translation"].
    Lockhart BP; Walther B
    Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using patent data to assess the value of pharmaceutical innovation.
    Kesselheim AS; Avorn J
    J Law Med Ethics; 2009; 37(2):176-83. PubMed ID: 19493065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the Development of Novel Cardiovascular Therapies.
    Hwang TJ; Kesselheim AS
    Clin Pharmacol Ther; 2017 Aug; 102(2):194-196. PubMed ID: 28643861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices for companion diagnostic and therapeutic development: translating between the stakeholders.
    Love D; Stratton E; Stocum M
    N Biotechnol; 2012 Sep; 29(6):689-94. PubMed ID: 22743138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Challenges and prospects for drug development of molecular targeting agents in Japan].
    Iwasaki M
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():695-702. PubMed ID: 23513923
    [No Abstract]   [Full Text] [Related]  

  • 12. A forensic analysis of drug targets from 2000 through 2012.
    Munos B
    Clin Pharmacol Ther; 2013 Sep; 94(3):407-11. PubMed ID: 23756372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process Improvement for Maximized Therapeutic Innovation Outcome.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2018 Jan; 103(1):8-12. PubMed ID: 29265398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical research and development: what do we get for all that money?
    Light DW; Lexchin JR
    BMJ; 2012 Aug; 345():e4348. PubMed ID: 22872694
    [No Abstract]   [Full Text] [Related]  

  • 15. How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?
    Burock S; Meunier F; Lacombe D
    Eur J Cancer; 2013 Sep; 49(13):2777-83. PubMed ID: 23777742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connections in pharmacology: innovation serving translational medicine.
    Montero-Melendez T; Perretti M
    Drug Discov Today; 2014 Jul; 19(7):820-3. PubMed ID: 24316023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987-2011.
    Lanthier M; Miller KL; Nardinelli C; Woodcock J
    Health Aff (Millwood); 2013 Aug; 32(8):1433-9. PubMed ID: 23918488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing risks in drug discovery: reproducibility of published findings.
    Kannt A; Wieland T
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):353-60. PubMed ID: 26883784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.